http://www.icis.com/icisconnect/blogs/chemblogwatch/archive/2009/06/16/more-changes-at-jubilant.aspxJubilant Organosys appears to be taking one more step in transforming itself into a pharmaceutical company. The company is looking at selling its industrial and performance products division and expects to realise Rs3.0-3.5bn from the sale, says thisenCommunityServer 2008.5 SP2 (Build: 40407.4157)